Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 5.52 Billion | USD 8.56 Billion | 5% | 2023 |
According to a report from Zion Market Research, the global Intravenous Infusion Pumps Market was valued at USD 5.52 Billion in 2023 and is projected to hit USD 8.56 Billion by 2032, with a compound annual growth rate (CAGR) of 5% during the forecast period 2024-2032. This report explores market strengths, weakness, opportunities, and threats. It also provides valuable insights into the market's growth drivers, challenges, and the future prospects that may emerge in the Intravenous Infusion Pumps Market industry over the next decade.
Intravenous medications play a major role in effectively managing hospitalized patients. Moreover, inpatients receive intravenous medicines more frequently and are delivered through infusion pumps. Nevertheless, though intravenous drugs provide a slew of benefits, few errors incur during administering these drugs in patients and this can also prove fatal for subjects. Furthermore, for reducing these errors smart intravenous infusion pumps have been embedded with software for providing point of care decision support services.
Additionally, this software comprises of medicine library profiles of patients and also provides information about proportion of drug doses to be administered in patients through these pumps. All these aspects will steer the growth of the intravenous infusion pumps market in upcoming years. Apparently, escalating requirement of bringing innovations in intravenous infusion pumps will produce new growth avenues for the intravenous infusion pumps industry in upcoming years. Smart intravenous infusion pumps are used by physicians for safe administration of medicines in patients. The product helps in delivery of precise drug doses automatically to patients at times set for providing those doses.
Surge in occurrence of chronic ailments such as cancer, heart disorders, and diabetes will prompt growth of intravenous infusion pumps market. Furthermore, spread of COVID-19 pandemic has resulted in massive demand for intravenous infusion pumps, particularly for patients in ICUs. In addition to this, these products helps in delivering spectrum of medicines such as anesthetic agents, antithrombotic, neuromuscular blocking agents, opioids, vasopressors, anesthetic agents, and antiarrhythmic agents. All these aforementioned factors will drive growth of intravenous infusion pumps industry over forecast timeline. Rise in aging population susceptible to chronic disorders and low product costs will drive penetration of intravenous infusion pumps in healthcare activities, thereby driving market trends.
Furthermore, a prominent increase in proportion of persons underdoing medical surgeries for cancer and other chronic disorders will proliferate size of intravenous infusion pumps market in years ahead. High product costs can prove to be hurdle in growth of the intravenous infusion pumps market in foreseeable future.
North America To Make Lucrative Contributions Towards Overall Market Size By 2032
The growth of the intravenous infusion pumps market in North America over forecast timeline is owing to surge in chronic ailments and rise in aging population in countries such as Canada and the U.S. Apart from this, acceptance of technologically advanced items for treating chronic diseases & other disease conditions of population will drive regional market trends. Presence of reputed players in countries such as the U.S. will embellish the expansion of the intravenous infusion pumps market in North America over assessment period.
Report Attributes | Report Details |
---|---|
Report Name | Intravenous Infusion Pumps Market |
Market Size in 2023 | USD 5.52 Billion |
Market Forecast in 2032 | USD 8.56 Billion |
Growth Rate | CAGR of 5% |
Number of Pages | 150 |
Key Companies Covered | ICU Medical Inc, B. Braun Melsungen AG, Terumo Corporation, Moog Inc, IRadimed Corporation, Baxter International Inc, Becton, Dickinson and Company, Mindray, Smiths Medical, and Zyno Medical |
Segments Covered | By Product Type, By End-User and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Key players profiled in study and influencing market growth are:
By Product
By End-User
FrequentlyAsked Questions
Surge in occurrence of chronic ailments such as cancer, heart disorders, and diabetes will prompt growth of intravenous infusion pumps market. Furthermore, spread of COVID-19 pandemic has resulted in massive demand for intravenous infusion pumps, particularly for patients in ICUs. In addition to this, these products helps in delivering spectrum of medicines such as anesthetic agents, antithrombotic, neuromuscular blocking agents, opioids, vasopressors, anesthetic agents, and antiarrhythmic agents. All these aforementioned factors will drive growth of intravenous infusion pumps industry over forecast timeline. Rise in aging population susceptible to chronic disorders and low product costs will drive penetration of intravenous infusion pumps in healthcare activities, thereby driving market trends.
Furthermore, a prominent increase in proportion of persons underdoing medical surgeries for cancer and other chronic disorders will proliferate size of intravenous infusion pumps market in years ahead.
According to Zion market research report, The Global Intravenous Infusion Pumps market accrued earnings worth approximately USD 5.52 Billion in 2023 and projected to USD 8.56 Billion by 2032, with a CAGR of around 5% between 2024-2032.
North America will contribute lucratively towards the global market size over the estimated timeline. The regional market surge is due to surge in chronic ailments and rise in aging population in countries such as Canada and the U.S. Apart from this, acceptance of technologically advanced items for treating chronic diseases & other disease conditions of population will drive regional market trends. Presence of reputed players in countries such as the U.S. will embellish expansion of intravenous infusion pumps market in North America over assessment period.
The key market participants include ICU Medical, Inc., B. Braun Melsungen AG, Terumo Corporation, Moog Inc., IRadimed Corporation, Baxter International Inc, Becton, Dickinson and Company, Mindray, Smiths Medical, and Zyno Medical.
The Intravenous Infusion Pumps market will be set to record a CAGR of nearly 5% over the period from 2024to 2032.
Influencing segment growing in the Intravenous Infusion Pumps Market are By Product (Volumetric Pumps, Syringe Pumps, And Patient –Controlled Analgesia Pumps), By End-User (Hospitals & Clinics And Home Healthcare), And By Region
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed